Home > National Drug Code (NDC) > BCG VACCINE

BCG VACCINE - 0052-0603-02 - (BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN)

Alphabetical Index


Drug Information of BCG VACCINE

Product NDC: 0052-0603
Proprietary Name: BCG VACCINE
Non Proprietary Name: BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
Active Ingredient(s): 50    mg/1 & nbsp;   BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
Administration Route(s): PERCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of BCG VACCINE

Product NDC: 0052-0603
Labeler Name: Organon Pharmaceuticals USA
Product Type: VACCINE
FDA Application Number: BLA103050
Marketing Category: BLA
Start Marketing Date: 19890621

Package Information of BCG VACCINE

Package NDC: 0052-0603-02
Package Description: 1 VIAL in 1 CARTON (0052-0603-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0052-0603-01)

NDC Information of BCG VACCINE

NDC Code 0052-0603-02
Proprietary Name BCG VACCINE
Package Description 1 VIAL in 1 CARTON (0052-0603-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0052-0603-01)
Product NDC 0052-0603
Product Type Name VACCINE
Non Proprietary Name BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name PERCUTANEOUS
Start Marketing Date 19890621
Marketing Category Name BLA
Labeler Name Organon Pharmaceuticals USA
Substance Name BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
Strength Number 50
Strength Unit mg/1
Pharmaceutical Classes Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],BCG Vaccine [Chemical/Ingredient],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE]

Complete Information of BCG VACCINE


General Information